Article History
Accepted: 11 September 2023
First Online: 26 September 2023
Declarations
:
: The authors have no conflicts of interest to report. MNP discloses the following. MNP has consulted for Opiant Therapeutics, Game Day Data, the Addiction Policy Forum, AXA, Baria-Tek, and Idorsia Pharmaceuticals; has been involved in a patent application with Yale University and Novartis; has received research support from Mohegan Sun Casino, Children and Screens and the Connecticut Council on Problem Gambling; has participated in surveys, mailings or telephone consultations related to drug addiction, impulse-control disorders or other health topics; has consulted for and/or advised gambling and legal entities on issues related to impulse control, internet use and addictive disorders; has performed grant reviews for research-funding agencies; has edited journals and journal sections; has given academic lectures in grand rounds, CME events and other clinical or scientific venues; and has generated books or book chapters for publishers of mental health texts.
: All participants provided digital informe consent; the study protocl followed institutional security and human subject procedures and obtained ethical approval at Ipos. All study procedures were approved and perfome in accordance with the ethcal standards of the 1965 Declaration of Helsinki andlater amendments.